Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development

R.L. Norris; J.H. Martin; E. Thompson; J.E. Ray; R.O. Fullinfaw; David Joyce; M. Barras; G.R. Jones; R.G. Morris

doi:10.1097/FTD.0b013e3181ea3e8a

Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development

R.L. Norris, J.H. Martin, E. Thompson, J.E. Ray, R.O. Fullinfaw, David Joyce, M. Barras, G.R. Jones, R.G. Morris

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	615-623
Journal	Therapeutic Drug Monitoring
Volume	32
Issue number	5
DOIs	https://doi.org/10.1097/FTD.0b013e3181ea3e8a
Publication status	Published - 2010

Access to Document

10.1097/FTD.0b013e3181ea3e8a

Cite this

Norris, R. L., Martin, J. H., Thompson, E., Ray, J. E., Fullinfaw, R. O., Joyce, D., Barras, M., Jones, G. R., & Morris, R. G. (2010). Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development. Therapeutic Drug Monitoring, 32(5), 615-623. https://doi.org/10.1097/FTD.0b013e3181ea3e8a

@article{b1c5391791cb42a39fd62ef49dc9917c,

title = "Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development",

author = "R.L. Norris and J.H. Martin and E. Thompson and J.E. Ray and R.O. Fullinfaw and David Joyce and M. Barras and G.R. Jones and R.G. Morris",

year = "2010",

doi = "10.1097/FTD.0b013e3181ea3e8a",

language = "English",

volume = "32",

pages = "615--623",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams & Wilkins",

number = "5",

}

Norris, RL, Martin, JH, Thompson, E, Ray, JE, Fullinfaw, RO, Joyce, D, Barras, M, Jones, GR & Morris, RG 2010, 'Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development', Therapeutic Drug Monitoring, vol. 32, no. 5, pp. 615-623. https://doi.org/10.1097/FTD.0b013e3181ea3e8a

TY - JOUR

T1 - Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development

AU - Norris, R.L.

AU - Martin, J.H.

AU - Thompson, E.

AU - Ray, J.E.

AU - Fullinfaw, R.O.

AU - Joyce, David

AU - Barras, M.

AU - Jones, G.R.

AU - Morris, R.G.

PY - 2010

Y1 - 2010

U2 - 10.1097/FTD.0b013e3181ea3e8a

DO - 10.1097/FTD.0b013e3181ea3e8a

M3 - Article

C2 - 20683393

SN - 0163-4356

VL - 32

SP - 615

EP - 623

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 5

ER -